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Abstract
Background: By 2025, it is estimated that approximately 1.8 million Australian adults (approximately 8.4% of the
adult population) will have diabetes, with the majority having type 2 diabetes. Weight management via improved
physical activity and diet is the cornerstone of type 2 diabetes management. However, the majority of weight loss
trials in diabetes have evaluated short-term, intensive clinic-based interventions that, while producing short-term
outcomes, have failed to address issues of maintenance and broad population reach. Telephone-delivered
interventions have the potential to address these gaps.
Methods/Design: Using a two-arm randomised controlled design, this study will evaluate an 18-month,
telephone-delivered, behavioural weight loss intervention focussing on physical activity, diet and behavioural
therapy, versus usual care, with follow-up at 24 months. Three-hundred adult participants, aged 20-75 years, with
type 2 diabetes, will be recruited from 10 general practices via electronic medical records search. The Social-
Cognitive Theory driven intervention involves a six-month intensive phase (4 weekly calls and 11 fortnightly calls)
and a 12-month maintenance phase (one call per month). Primary outcomes, assessed at 6, 18 and 24 months, are:
weight loss, physical activity, and glycaemic control (HbA1c), with weight loss and physical activity also measured
at 12 months. Incremental cost-effectiveness will also be examined. Study recruitment began in February 2009,
with final data collection expected by February 2013.
Discussion: This is the first study to evaluate the telephone as the primary method of delivering a behavioural
weight loss intervention in type 2 diabetes. The evaluation of maintenance outcomes (6 months following the end
of intervention), the use of accelerometers to objectively measure physical activity, and the inclusion of a cost-
effectiveness analysis will advance the science of broad reach approaches to weight control and health behaviour
change, and will build the evidence base needed to advocate for the translation of this work into population
health practice.
Trial Registration: ACTRN12608000203358
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Background
Type 2 diabetes - a population health problem
The rapid increase in the prevalence of type 2 diabetes,
obesity and associated complications is a major public
health problem. In Australia, data from the 1999-2000
AusDiab study estimated that approximately 1 million
(7.4%) Australian adults aged 25 years and over have
type 2 diabetes [1], with approximately 85% being over-
weight or obese [2]. The growing epidemics of type 2
diabetes and obesity have been concurrent, with the pre-
valence of both doubling over the past 20 years [1]. The
prevalence of type 2 diabetes is predicted to increase
dramatically over the next few decades; projections are
that by 2030, 8.4% Australian adults aged 20-79 will
have the disease [3]. Similar rapidly increasing preva-
lence estimates have been reported for the UK [3], USA
[3,4] and other developed and developing countries [3].
Identified as the seventh leading cause of death among
Australian adults, type 2 diabetes is a major cause of
premature mortality and morbidity due to cardiovascu-
lar, renal, ophthalmic and neurological disease [5]. Data
from the DiabCost Australia study, which assessed the
total costs of type 2 diabetes to the health care system,
society, government and carers, estimated that $3 billion
a year is spent treating type 2 diabetes [6]. Since the
burden of illness associated with type 2 diabetes
increases with the onset of microvascular and macrovas-
cular complications [6], there is high priority for effec-
tive and sustainable strategies to slow or prevent the
onset of complications. The value of achieving glycaemic
control is underscored by the landmark findings of the
UK Prospective Diabetes Study, a 10 year observational
follow-up in patients with diabetes, whereby each 1%
reduction in glycosylated haemoglobin (HbA1c) was
associated with a 14% reduction in myocardial infarc-
tion, a 37% reduction in microvascular events, and a
21% reduction in diabetes-related mortality [7]. This is
of particular importance for people with type 2 diabetes
since coronary heart disease is responsible for about
70% to 80% of deaths in this population [8].
Lifestyle factors that adversely affect energy balance
(physical inactivity and over-nutrition) play a major role
in the development of both type 2 diabetes and obesity
[9,10]. The importance of weight management, by
means of a healthy, energy-restricted diet and a physi-
cally active lifestyle, is considered to be the primary
approach in the treatment of overweight and obesity
[11,12] and is widely acknowledged as a cornerstone of
the management of type 2 diabetes and its related mor-
bidities [13]. There is also evidence that many of the
traditional pharmacologic approaches frequently used to
treat diabetes contribute to weight gain [14]. Weight
loss or weight management is an important therapeutic
task for most people with type 2 diabetes, not only for
improved glycaemic control but also for reducing cardi-
ovascular disease (CVD) risk [13]. A modest weight loss
of 5-10% of body weight has been associated with
improvements in fasting plasma glucose, HbA1c, insulin,
lipid levels, and blood pressure [10]. In addition, there is
compelling epidemiologic and experimental evidence
that physical activity confers substantial protection
against CVD and premature mortality in those with type
2 diabetes, independent of weight loss, through its
favourable effects on blood pressure, blood glucose,
insulin sensitivity, lipid profile, fibrinolysis, endothelial
function and inflammatory defence systems [15,16].
At present in Australia, type 2 diabetes is managed
primarily in the general practice setting (primary care).
In addition to medication management and monitoring
of glycaemic control, this may include brief lifestyle
advice from General Practitioners (GPs), and for some,
a Diabetes Care Plan that includes referral for a limited
number of visits to diabetes educators, dietitians, exer-
cise physiologists and other allied health professionals.
Given the challenge of health behaviour change and
weight loss, and the need for ongoing assistance to
maintain such changes, approaches that work in concert
with primary care are needed, with such approaches
involving more behaviourally-focussed and longer-term
self-management supports [17].
Lifestyle management and weight loss intervention trials
in type 2 diabetes
There is a large literature on lifestyle management and
weight loss interventions in type 2 diabetes, including the
current landmark Look AHEAD trial, which is evaluating
an intensive four-year weight loss intervention to reduce
cardiovascular morbidity and mortality [18,19]. Across
numerous studies, there is clear evidence that intensive life-
style interventions involving reduced energy (and fat)
intake, regular physical activity, cognitive behaviour
therapy and frequent participant contact will produce sig-
nificant behavioural improvements, as well as weight loss
(5-7% of body weight) and concomitant improvements in
glycaemic control and dyslipidaemia [10,20,21]. However,
there are a number of gaps in this literature that make its
findings less relevant to informing a population-based
approach to the lifestyle management of type 2 diabetes.
First, the majority of trials have evaluated intensive, clinic-
based interventions that are similar to the diabetes educa-
tion programs offered through hospitals as part of clinical
management. While these clinic-based interventions are
effective [22], few patients with type 2 diabetes take part in
such programs [23]. Second, very few studies include a
post-intervention follow-up assessment to determine
whether improvements are maintained longer term [24,25].
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Broad reach weight loss and lifestyle intervention trials
A number of recent studies have evaluated weight loss
interventions delivered via telephone, tailored print and
the internet [26-31]. Of note are two recent studies
which have evaluated a telephone-delivered approach for
initiation and maintenance of weight loss [29,31]. One
study observed similar short-term weight loss at
6-months for both face-to-face (8.9%) and telephone-
delivered (7.7%) interventions [29]. In the other trial,
following initial weight loss at 6 months, small but statis-
tically non-significant regain in weight was observed for
those in the 12-month telephone and face-to-face main-
tenance contact groups, which was significantly less than
the regain observed in the control group [31].
Telephone-delivered interventions have the potential
for widespread and cost-effective population reach, and
have been widely researched [32-38]. A systematic review
of 26 telephone-delivered physical activity and dietary
behaviour intervention studies found very strong support
for their efficacy to produce short-term behavioural
changes in both people with and without chronic condi-
tions, with 20 of 26 studies reporting significant beha-
vioural improvements immediately post-intervention
[39]. Interventions lasting six to 12 months and those
including 12 or more calls produced the most favourable
outcomes. Our own work in this area has shown tele-
phone-delivered interventions to be effective in promot-
ing both initiation and maintenance [40,41] of dietary
change, as well as demonstrating cost-effectiveness [42].
Purpose
This paper describes the methods of the Living Well
with Diabetes trial which is evaluating a telephone-
delivered behavioural weight loss intervention focussing
on physical activity, diet and behavioural therapy in
adults with type 2 diabetes. To promote maintenance
the 18 month intervention has an intensive first
6 months focussed on initiation of behaviour change,
followed by 12 months focussed on enhancing/support-
ing maintenance. Measurement at baseline, six, 12, 18,
and 24 months allows for assessment of initiation and
maintenance of change - a major contribution of the
study to the evidence base on broad reach interventions
to support weight loss and lifestyle management in type
2 diabetes.
Methods/Design
Study design
Living Well with Diabetes is a two-arm randomised con-
trolled trial evaluating a telephone-delivered behavioural
weight loss intervention versus usual care in adults with
type 2 diabetes. Ethical approval was granted from The
University of Queensland Behavioural and Social
Sciences Ethical Review Committee.
Setting
Participants are recruited from general practices in the
city of Logan (population 270,000), a large ethnically
and socioeconomically diverse community in Queens-
land, Australia, which sits 35 kilometres from Brisbane
(the state capital), and an urban centre of 1.8 million
residents.
Practice sampling and recruitment
General practices are recruited from the Southeast Pri-
mary Health Care Network (SPHN), a state and federally
funded organization that provides administrative, techni-
cal and professional development/educational support to
local area practices. At study commencement, SPHN
supported 76 practices. The study will recruit 10 prac-
tices over two years, with approximately 30 adults
enrolled from each practice. To ensure an adequate
patient sampling frame from each practice, practices are
ranked in order of descending number of GPs, with the
largest practices approached first on a rolling basis until
10 practices (or the required sample size of 300 partici-
pants) consent to participate. Practices are initially con-
tacted by telephone to determine whether electronic
medical records can be used to perform patient searches
by medical condition, and whether approximately 200
patients with type 2 diabetes can be identified. Eligible
practices are sent an invitation letter and study bro-
chure. This is followed-up by a phone call from a GP
working within the SPHN (author KW), and a practice
visit from the project manager to solicit consent.
Patient sampling and recruitment
Within practices, electronic medical records are
searched for potentially eligible patients. Eligibility is
based on: diagnosed type 2 diabetes; aged 20-75 years;
and having a listed telephone number. The lists of
potentially eligible participants are initially screened by
treating GPs for the following contraindications to an
unsupervised physical activity and weight loss interven-
tion: active heart disease, breathing problems requiring
hospitalisation in the past 6 months, undergoing dialysis,
taking Warfarin, diabetic complications such as severe
neuropathy or retinopathy, planning a knee or hip repla-
cement in the next 12 months, regular use of a mobility
aid or pregnant. In addition, GPs are asked to screen
out those who are undergoing cancer treatment (exclud-
ing hormone therapy), those from non-English speaking
backgrounds and those with significant difficulty with
written materials or with hearing problems that would
make telephone contact prohibitive.
Eligible patients, based on GP screening, receive a let-
ter from their GP informing them of the study, along
with a study brochure and an expression of interest
form with a return, pre-paid envelope. Patients not
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returning the form within two weeks receive a follow-up
phone call from practice staff. Those patients returning
the expression of interest form and those providing ver-
bal consent to contact are posted a study information
sheet and consent form. They then receive a call from
study staff during which a detailed explanation of the
study is provided, patients are re-screened for eligibility
based on the same criteria as GPs (to account for varia-
tion in GP screening), and some additional exclusion
criteria - current or planned (next 12-months) use of
weight loss medications (e.g. Xenical, Reductil), and pre-
viously had or planning bariatric surgery. During this
call, participants are also screened for self-reported
baseline levels of physical activity and weight, and are
excluded from study participation if they meet or exceed
physical activity guidelines (30 minutes of moderate to
vigorous physical activity on five or more days/week
[43] AND are not overweight (defined as a body mass
index [weight in kilograms/height in metres2] of < 25.0
kg/m2) [44]. In addition, for those with a self-reported
BMI ≥ 45 kg/m2, suitability for participation in unsuper-
vised weight loss is confirmed from their GP. Consent
to participate in the study is then sought from those
considered eligible. De-identified data on eligible non-
participants is obtained from medical records to
compare demographic (age and sex) characteristics of
participants and non-participants.
Randomisation
Following baseline data collection, allocation to study
groups (telephone intervention or usual care) is con-
ducted using the method of minimization to ensure
equal group balance across factors likely to impact on
primary study outcomes [45,46]. Minimisation factors
based on baseline data collection include: gender, age
(< 55 years; ≥ 55 years), BMI (< 40 kg/m2; ≥ 40 kg/m2),
HbA1c (< 8%; ≥ 8%), physical activity level (meeting
guidelines of at least 150 minutes/week and 5 or more
sessions; not meeting guidelines) [47], and diabetes
management (insulin or combination therapy; traditional
oral hypoglycaemic medications; new glucose-lowering
medications (e.g. Byetta, Januvia); lifestyle alone). Alloca-
tion is performed using the free Minim computer soft-
ware [48] and conducted by a research assistant with
minor involvement in participant recruitment. The time-
frame from participant recruitment to group allocation
ranges from approximately three to eight weeks to allow
for extensive baseline data collection (see Data Collec-
tion section below), and not all minimisation factors are
known at recruitment (e.g. HbA1c level, diabetes man-
agement). Therefore, the ability for the staff member to
predict with certainty, the allocation of participants at
recruitment, a criticism of the minimisation method
[46], is near impossible.
Usual care
In order to minimise attrition over the 24-month study
duration, participants in the usual care group receive a
thank you letter and brief summary following each
assessment. At baseline, 6-, 12- and 18-months they are
also posted standard, off-the-shelf diabetes self-manage-
ment education brochures (from Diabetes Australia)
with information on diabetes education and a variety of
health behaviours. These are consistent with the materi-
als generally given to patients as part of their usual dia-
betes care. GPs for all patients in the study are also sent
brief summaries of their patients’ assessment results.
Telephone-delivered weight loss intervention
The weight loss intervention, delivered entirely over the
telephone, uses a combined approach of increasing phy-
sical activity, reducing energy intake and behavioural
therapy [11,12]. It is based on current evidence for
initiation and maintenance of weight loss and clinical
practice guidelines for the management of overweight/
obesity and type 2 diabetes. Participants receive a
detailed workbook at the commencement of the inter-
vention and up to 27 telephone calls over 18 months, to
support both initiation and maintenance of weight loss.
Call frequency is somewhat flexible, so that it can be tai-
lored to the needs of the participant. For example, an
extra weekly call might occur during a period of relapse.
Intervention targets for physical activity, dietary intake
and weight loss are consistent with management goals
for type 2 diabetes [10], with the aim to reduce glycosy-
lated haemoglobin (HbA1c) to less than 7% [11,49,50].
As described in detail below, participants work with
their telephone counsellor to identify small, gradual
changes to physical activity and dietary intake and that
are able to be maintained long-term, rather than large
and highly restrictive changes which are less likely to be
maintained [11,51], as described below. Participants are
encouraged to aim for moderate weight loss of 5-10% of
initial body weight [10,21], with a loss of 1-2 kg per
month.
Physical activity
A target of 210 minutes per week (30 minutes every
day) of moderate-intensity, planned activity is encour-
aged, consistent with the level of physical activity neces-
sary to promote weight loss [49]. Given evidence
suggesting that even higher levels of activity (i.e., 60
minutes/day) may be necessary for weight loss mainte-
nance [52], those who can do more activity will be
encouraged to work towards this during the mainte-
nance phase. The telephone counsellor works with parti-
cipants to first identify types of activities that they enjoy
and can be easily incorporated into their lifestyle (e.g.,
walking), rather than providing a structured exercise
program [11,53]. As most participants are relatively
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inactive at baseline, increases in physical activity are
initially small and gradually increase towards the goal of
30 minutes per day of moderate-to-vigorous intensity
activity [49].
Resistance exercise (2-3 sessions/week) is also encour-
aged, as strength training has benefits for glycaemic
control [54] and is consistent with the physical activity
guidelines for older adults [55]. Participants are provided
with a resistance band, and detailed photographs and
instructions are included in the workbook with guide-
lines on the number of sets and repetitions of each exer-
cise, along with options for progression.
In addition to daily planned physical activity, partici-
pants are encouraged to take opportunities to be active
in and around their homes and workplaces (e.g. garden-
ing, housework, taking the stairs), and to reduce sitting
time (i.e., to get up and move every 30 minutes and to
aim for no more than 2 hours/day of screen time out-
side of work). This is consistent with evidence on the
health benefits conferred by light-intensity activity
[56-58], and with newer evidence on the cardio-meta-
bolic consequences of too much sitting [59,60].
Diet
Participants are encouraged to reduce energy intake by
2,000 kJ per day through individualised advice to allow
for specific food preferences and approaches [10,12,61].
That is, the intervention does not use meal replace-
ments or structured meal plans. Specific macronutrient
compositions are not prescribed (e.g. high protein/low
carbohydrate or high carbohydrate/moderate protein) as
evidence on long-term maintenance of weight loss has
shown similar outcomes for both types of diet [62-64].
A low fat diet (< 30%) is encouraged as this has been
associated with long-term weight loss maintenance [52],
as are a saturated fat intake of < 7% of energy and fibre
intake of 25 grams/day for women and 30 grams/day for
men, consistent with dietary recommendations for peo-
ple with type 2 diabetes to reduce risk factors for cardi-
ovascular disease [65]. Strategies to reduce energy intake
include - improving portion control (by reducing por-
tion size or number of serves) and lowering energy den-
sity (by increasing intakes of low energy foods such as
fruits and vegetables and reducing intake of energy
dense foods such as high fat foods). Regular meal pat-
terns with an emphasis on eating breakfast are pro-
moted [66].
Behavioural therapy
Behaviour change strategies and principles used to guide
the intervention are derived from Social Cognitive The-
ory (SCT) [18], specifically developing knowledge and
skills related to the SCT constructs of self-efficacy,
social support and outcome expectancies. The matrix in
Table 1 and the text below describe the way in which
these are operationalized. No single behaviour strategy
has been shown to be better than any other in terms of
effects on weight loss, and thus multi-modal strategies
are used [11,12]; although some strategies (i.e., self-mon-
itoring) have been associated with better weight loss
maintenance outcomes [67]. Behaviour change skills
emphasised in this intervention include: self-monitoring,
goal setting, problem solving, social support, stimulus
control, positive self-talk, and self-reward.
Participants are provided with self-monitoring ‘track-
ers,’ to monitor their daily physical activity and food
intake, and are encouraged to weigh themselves once to
twice weekly. Participants are provided with a ped-
ometer to monitor daily steps and with a set of digital
scales to monitor their body weight.
Participants are encouraged to set small, measurable and
achievable health behaviour change and weight loss goals
that facilitate a sense of confidence and mastery that can
be built upon throughout the intervention and hence
build self-efficacy. These are recorded on a large, reusable
refrigerator magnet. Problem solving is used to help parti-
cipants identify barriers to their behaviour change goals
and identify strategies and solutions to overcome these.
Participants are encouraged to identify a broad array
of possible supports for weight loss (e.g., from family
and friends co-workers, the general practitioner, neigh-
bourhood or community programs) and to set specific
goals for drawing upon these [68]. Stimulus control (or
behaviour cue) techniques are used to create more sup-
portive environments for health behaviour change and
weight loss (e.g. keeping problem foods out of the
house; putting left-overs in the freezer immediately;
leaving walking shoes by the bedside). Positive self-talk
(e.g. focussing on what has been achieved rather than
what has been given up) is encouraged as a means of
addressing habitual negative thinking [69], and self-
rewards for goal attainment are promoted to reinforce
behaviour change.
Telephone counsellor background and training
All telephone counsellors have at least bachelor’s level
training in nutrition and dietetics; some have also com-
pleted a dual-degree in exercise physiology. They
undergo one month of intensive training in study proto-
cols and a motivational interviewing approach to health
behaviour counselling [70] (including role plays with
study investigators). Telephone counsellors have
ongoing quality assurance checks via randomly taped
telephone calls and fortnightly clinical supervision meet-
ings. In addition, call attempts, completions and dura-
tion are tracked, and a call content checklist completed
after each call to inform an evaluation of intervention
fidelity. To the extent possible, the same telephone
counsellor remains with participants throughout the
duration of the intervention to facilitate rapport and
continuity of care.
Eakin et al. BMC Public Health 2010, 10:452
http://www.biomedcentral.com/1471-2458/10/452
Page 5 of 15
Intervention procedures
Intervention delivery is guided by a patient-centred,
chronic disease self-management intervention model
used in previous trials (Figure 1) [37,71], and by techni-
ques of motivational interviewing [70]. An iterative pro-
cess is used in each call: it draws upon repeated
assessment of study outcomes and participant self-moni-
toring; feedback is provided in relation to study targets
for weight, dietary intake and physical activity, and con-
sistent with a motivational interviewing approach, this
feedback highlights the discrepancy between participant
goals and their current health behaviours; collaborative
goals for weight, physical activity and dietary change are
set with the telephone counsellor, with an emphasis on
achievability and measurability. Each intervention con-
tact results in a behaviourally-specific Action Plan that
specifies exactly what is to be done and when; barriers
and supports are identified; confidence is assessed and
problem-solving is discussed as necessary. These steps
are repeated during intervention calls, with goals being
adjusted as necessary.
A semi-structured approach to both the content and
the order in which intervention targets are addressed is
used to guide intervention delivery (see Table 2). How-
ever, consistent with the motivational interviewing
approach, the intervention is tailored to each partici-
pant, with an initial focus on targets in which she/he is
most motivated and most confident in changing.
Phase 1 (month 1) The first month of the intervention
involves up to four weekly calls, with a focus on building
rapport (e.g. providing feedback on the baseline assess-
ment and understanding what the participant wants to
Table 1 Theory matrix
Social-Cognitive Theory Constructs Operationalization
Self-efficacy Realistic and measurable goal-setting
Assessing confidence
Self-monitoring
Practicing positive self-talk
Social support Developing a support network (family/friends/others)
Setting goals around using supports
Outcome expectancies Benefits and barriers to health behaviour change
Problem-solving approach to addressing barriers
Rewards for goal attainment
Figure 1 Chronic Disease Self-Management Intervention Model.
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get out of the program); education on weight loss (e.g.
energy balance); and skill-building (e.g. self-monitoring
and goal-setting). The emphasis is on helping participants
to gain the knowledge and skills necessary to achieve
behaviour change and weight loss in the next phase.
Phase 2 (months 2-6) Up to 11 fortnightly calls are
completed during this phase, with an emphasis on initial
behaviour change, weight loss and continued confidence
and skill-building. Behaviourally-specific goal setting
with regard to the amount of physical activity and diet-
ary change that is needed to achieve weight loss is the
focus, along with problem-solving and continued self-
monitoring.
Phase 3: (months 7-18) This phase of the intervention
involves 12 calls over 12 months (one per month) with
a focus on maintenance of behaviour change and weight
loss. During this phase, participants not yet reaching
their initial weight loss, physical activity and/or dietary
behaviour change targets are encouraged to continue to
work towards these; those who have reached initial tar-
gets focus on strategies for maintaining weight loss and
behaviour change. In addition to continued support
from telephone counsellors, other strategies to promote
maintenance include: ongoing self-monitoring, enlisting
social support (from family, friends and health care pro-
viders), and use of community resources to support life-
style change (e.g., weight loss groups, walking tracks,
gym membership).
Primary and secondary outcomes
Primary outcomes are: change in weight (kg), acceler-
ometer-measured moderate-to-vigorous physical activity
Table 2 Telephone Intervention Overview: Call Frequency and Content
Intervention stage & call
frequency
Purpose Content
Phase 1:
(Month 1)
4 weekly calls
Building rapport
Education
Skill-building
Program introduction/explanation
Participant overarching program goals
Feedback on baseline assessment
Review & goal-setting:
Weight loss: benefits, energy balance, realistic targets, portion sizes,
recommended
serves, reducing fat intake
Behaviour change skills: self-monitoring, goal-setting
Begin use of scale, pedometer and food diary
Phase 2:
(Months 2-6)
11 fortnightly calls
Behaviour change
Weight loss
Skill-building
Review & goal-setting:
Physical activity: planned activity, incidental activity, sitting time,
strength training
Diet: reducing energy intake (choosing lower energy foods, swapping
higher energy
foods for lower energy foods, decreasing intake of high energy foods/
drinks), eating
habits, food labels, modifying recipes
Behaviour change skills: rewards, behavioural cues, barriers and supports
Progress review at 3 months
Phase 3:
(Months 7-18)
12 monthly calls
Maintenance of behaviour change &
weight loss
Feedback on 6-, 12- & 18-month assessments
Progress review at 9 & 15 months
Review & goal-setting:
Role of physical activity in maintaining weight loss
Problem-solving
Social-environmental support
Developing lifelong habits
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and glycaemic control (HbA1c). Secondary outcomes
are: change in self-reported dietary and energy intake,
accelerometer-measured light intensity and sedentary
time, objectively measured waist circumference, percent
body fat, fasting plasma glucose and blood lipids (total
cholesterol, HDL-cholesterol, LDL-cholesterol, triglycer-
ides), liver function enzymes, blood pressure, along with
self-reported SCE constructs, medication use and
health-related quality of life. We will also evaluate the
incremental cost-effectiveness of the telephone interven-
tion and examine demographic and health-related mod-
erators of intervention effects and mediators consistent
with the underlying theoretical basis. Related measures
are described below and summarised in Table 3.
Data collection
Data are collected via objective measurements conducted
in participants’ homes, telephone interviews, and self-
administered questionnaires at baseline, 6-, 18-, and 24-
months by research staff and registered nurses blind to
participants’ study group. At 12 months, weight, waist cir-
cumference and accelerometer-derived physical activity
are also assessed. Home visits are conducted by registered
nurses and include objective measurement of: height
(baseline only; Seca 214 height rod, Seca, Germany),
weight, waist circumference, body composition, blood
pressure and collection of blood samples for biochemical
assay. In addition, details of diabetes medications (drug
and dosage) and any use (yes/no) of antihypertensive and
lipid-lowering medications are also collected during this
visit. Telephone interviews collect self-report data on:
demographics (gender, age, education, income, type and
number of chronic conditions; baseline only), and vali-
dated measures of physical activity, diet, quality of life and
health care use, as well as items to assess sleep, diabetes
history and management, use of weight loss aids and
adverse outcomes. Self-administered questionnaires are
used to collect data related to the social-cognitive and
environmental constructs which underpin the intervention
and to assess depression. In addition to the self-reported
physical activity collected via the telephone interviews,
accelerometers are used to collect objectively-measured
physical activity and sedentary time. Data related to inter-
vention delivery are also tracked by telephone counsellors
following each call. This includes data on call outcomes
(call completion versus missed calls), call duration and call
content (via a checklist of topics). Details of the measures
are provided below and summarised in Table 3.
Anthropometric outcomes
Weight loss Weight is measured without shoes or heavy
clothing to the nearest 0.1 kg using standard calibrated
scales (Model TI TBF 350, Tanita Inc., Tokyo, Japan).
Waist circumference Waist circumference is measured
with a non-expandable tape to the nearest 0.5 cm at the
superior border of the iliac crest [12,72]. Waist measure-
ments are taken in duplicate and a third measurement
taken if the first two differ by more than 1 cm. The
mean of the measurements is used.
Body composition Fat mass (kg), fat free mass (kg) and
percent body fat are measured using foot-to-foot bioe-
lectrical impedance analysis (Model TI TBF 350, Tanita
Inc., Tokyo, Japan) in the fasted state. Body composition
measurements are not performed on participants with a
pacemaker.
Cardio-metabolic outcomes
Blood samples are taken early in the morning after an
overnight fast (at least 10 hours), with participants
instructed not to take any glucose-lowering medication
prior to the assessment.
Glycaemic control HbA1c is measured from whole
blood samples by the high performance liquid chroma-
tography method (Bio-Rad Variant II, Sydney, Australia).
Plasma glucose is measured by the hexokinase method
(Roche Modular Analyzer; Tokyo, Japan).
Blood lipids Total cholesterol, high density lipoprotein
(HDL) cholesterol and triglycerides are measured by an
enzymatic colorimetric assay with Roche Modular
Chemistry Analyser (Tokyo, Japan). Low density lipo-
protein (LDL) cholesterol is determined using the Frie-
dewald equation [73,74].
Liver function tests Liver enzymes - alanine amino-
transferase (ALT), aspartate amino-transferase (AST),
lactate dehydrogenase (LDH), alkaline phosphatase
(ALP), gamma glutamyl transpeptidase (GGT) - are
measured using Roche Modular (Tokyo, Japan).
Blood pressure Blood pressure is measured in the
seated position by a portable sphygmomanometer
(Gamma G5, Heine, Germany) using the non-dominant
arm and an appropriately sized cuff. Two readings are
taken and a third measurement taken if the first two dif-
fer by more than 10 mmHg systolic or 6 mmHg diasto-
lic, or if the first two readings are more than 140/90
mmHg. Blood pressure is recorded as the mean of the
readings taken.
Medication use Details of diabetes medication (oral
medication and insulin) are collected by registered
nurses from prescription containers - medication name,
dose prescribed and daily quantity taken. Participants
are also asked to report whether they are taking anti-
hypertensive or lipid-lowering medications.
Behavioural outcomes
Objectively-measured physical activity and sedentary
time A dual-axis accelerometer (Actigraph model
GT1M; Actigraph, LLC, Fort Walton Beach, Florida),
fitted firmly around the waist by elasticised band and
positioned on the right mid axillary line, is used to
objectively-derive physical activity and sedentary time.
Participants are instructed to wear the accelerometer
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during all waking hours (removing for any water based
activities) for a continuous period of seven days, and to
record time worn in a wear-time log. The study nurse
demonstrates how to wear the accelerometer and com-
plete the wear-time log. Research staff then telephone
the participant to negotiate a start date and reiterate the
instructions; the accelerometer and wear-time log are
then posted to participants. On the (expected) seventh
day of wear, a follow-up telephone call is made by
research staff to ensure adequate wear time and to
prompt accelerometer return in a reply-paid envelope.
The protocol for the follow-up assessment is identical
with the exception that the registered nurse does not
repeat the demonstration and instructions at the
assessment.
Accelerometer data are collected in one minute
epochs. A generic program (SAS 9.1), modified from the
National Cancer Institute [75], is used to identify
Table 3 Summary of Measures
Anthropometric #Weight
#Waist circumference
% body fat
Cardio-metabolic Glycoslyated haemoglobin
Fasting blood glucose
Cholesterol (total, HDL, LDL)
Triglycerides
Liver function tests (ALT, AST, LDH, ALP, GGT)
Blood pressure
Diabetes medication
Behavioural #Objectively measured physical activity (PA) via accelerometer
Average mod-vig PA/day (mins)
Average light intensity PA/day (mins)
Average very light intensity PA/day (mins)
Average sedentary time/day (mins)
Breaks in sedentary time (n/day)
Bouts of moderate-to-vigorous intensity activity (n/day)
Self-reported physical activity
Walking (days & min/wk)
Walking for exercise (days & min/wk)
Moderate-vigorous PA (days & min/wk)
Resistance training (days & min/wk)
Sitting items (transport, television, computer min/wk)
Self-reported diet
Dietary intake (total energy, total fat, saturated fat, fibre)
Dietary behaviour
Sleep (duration & quality)
Psychosocial-Environmental Depression
Self-efficacy
Social support
Perceptions of the neighbourhood environment
Cost-effectiveness Health-related quality of life
Health care utilization
Cost to deliver intervention
Intervention Delivery (tracked for each call) Call duration
Call completion
All assessed at baseline, 6, 18 & 24 months; #assessed at 12 months; bold text denotes primary outcome
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outliers and summarise daily variables. The wear time
syntax of the program, based on a combination of the
wear-time logs and the accelerometer data, is modified
for each participant in order to maximise the accuracy
of the wear time estimation. Invalid days of observation
(days with < 10 hours wear or excessive counts ≥ 20,000
counts per minute: cpm) will be discarded. Daily seden-
tary (< 100 cpm), very light-intensity activity (100 to
759 cpm), light-intensity activity (760 to 1951 cpm),
moderate-intensity activity (1952 to 5724 cpm), and vig-
orous-intensity activity (≥ 5 725 cpm) [76,77] time are
calculated and standardised for wear time using the resi-
duals method [78]. Patterns of physical activity and
sedentary time accumulation (for example, breaks in
sedentary time [79] and bouts of moderate-to-vigorous
intensity activity) [80] are examined. Data are reported
as averages for valid days. The data collection and analy-
tic protocol comply with the best-practice guidelines for
conducting accelerometer-based activity assessments in
field-based research [81].
Self-reported physical activity Self-reported physical
activity is measured by the Active Australia Survey
(AAS), a 6-item measure assessing frequency and total
duration per week spent on walking, vigorous and mod-
erate physical activities over the last seven days [47].
The frequency items have been adapted to ask about
number of ‘days per week’ instead of ‘sessions per week’.
Total minutes of physical activity is calculated from the
sum of walking, moderate and 2 × vigorous minutes and
truncated at 1,680 minutes per week [47]. Two items
from the U.S. National Health Interview Survey (NHIS)
have been adapted to assess the number of days and
amount of time in the past week spent walking for exer-
cise [82]. The AAS has been found to have acceptable
validity and reliability [83], the NHIS items have shown
acceptable validity [82] and both items have shown simi-
lar or greater responsiveness to change compared to a
more detailed self-report instrument [84].
Self-reported resistance training Using a response for-
mat similar to that of the AAS, the number of days and
total number of minutes per week of resistance training
are collected using an unvalidated item [85].
Self-reported sitting time Six items are used to assess
total time spent sitting in the last week across three
domains - 1) transport, 2) watching television, videos or
playing electronic games and 3) leisure-time computer
use - asked separately for weekdays and weekend days.
These items have shown good test-retest reliability
(unpublished data).
Dietary intake Diet is assessed using the Anti-Cancer
Council of Victoria (ACCV) Food Frequency Question-
naire (FFQ) (version 2). The FFQ includes 74 food items
and six alcoholic beverage items with responses on a 10-
point scale (1 = Never to 10 = 3 or more times per day),
four pictorial questions relating to portion size, one
question on quantity of alcoholic beverages and 10
cross-check questions used to adjust for overestimation
and types of food products consumed (milk, bread,
spread and cheese) [86]. It was modified to ask about
intake over the previous month instead of the previous
12 months and to be telephone administered instead of
self-administered (participants receive a copy of the por-
tion size pictures in the mail). Nutrient intakes are com-
puted from FFQ responses using software developed by
the ACCV based on the NUTTAB95 nutrient composi-
tion data [87]. The questionnaire estimates intakes of
most nutrients accurately (within 10%) and does not
systematically under- or over-estimate against weighed
records [86].
In addition to the FFQ, dietary behaviours and intakes
of specific food groups will also be assessed. Servings of
vegetables and fruit are assessed using items from the
Australian National Nutrition Survey which have
demonstrated validity against more comprehensive self-
reported measures [88] and biomarkers (serum carote-
noids and red-cell folate) [89]. The 20-item Fat & Fibre
Behaviour Questionniare is also administered. This
questionnaire was used in our previous trial [40] and
adapted from other short dietary questionnaires [90-93]
to assess behaviours related to fat and fibre intake that
were targeted as part of the intervention. This index has
shown good two-week test-retest reliability (ICC = 0.87-
0.89), Pearson’s correlations of 0.50-0.56 for relative
validity compared to FFQ and similar or higher respon-
siveness compared to FFQ (unpublished data).
Sleep A single item to assess sleep duration on week-
days or workdays in the past week (reported in hours
and minutes) was adapted from an existing instrument
with established reliability and validity [94-96]. A single
item to assess sleep quality (in terms of feeling rested
upon awakening; rated from 1 = excellent to 5 = poor)
was created.
Psychosocial-environmental outcomes
Depression Measured using 9-items from the PRIME-
MD Patient Health Questionnaire (PHQ) assessing
depressive symptoms over the last two weeks, with
items answered on a 4-point scale (0 = not at all; 1 = sev-
eral days; 2 = more than half the days; 3 = nearly every
day). Items are summed such that higher scores indicate
a higher depression symptom severity, which has shown
good criterion validity compared to a Mental Health
Professional interview (r = 0.84) [97].
Eating and exercise self-efficacy Measured using a 10-
item questionnaire that assesses confidence in ability to
follow exercise and eating plans in difficult situations
(e.g., confidence in exercising when sore or tired; confi-
dence to choose healthy food options when bored) [98].
Items are answered on a scale from 0 (not at all
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confident) to 8 (extremely confident), and summed to
create a 5-item eating self-efficacy scale and 5-item
exercise self-efficacy scale, which have shown good
internal consistency - Cronbach’s a = 0.87 and 0.91,
respectively [98].
Confidence in weight loss Using the format and scale
above, a single item on confidence in losing weight
through exercise and healthy eating was adapted for this
study from the Multidimensional Diabetes Question-
naire [99].
Social support for diet and physical activity Measured
using a 20-item questionnaire assessing the frequency of
family and friend support over the previous three
months for healthy eating and exercise (e.g. complimen-
ted you on your progress in making healthy changes to
your diet; exercised with you); answered on a 5-point
scale (1 = none of the time; 5 = very often) [100]; and
summed separately for diet and physical activity. The
questionnaire was adapted to ask about support received
from ‘friends, family or members of your household’
combined, instead of asking questions separately for
support from ‘friends’ and from ‘family.’
Perceptions of the neighbourhood environment Mea-
sured using 10-items created to assess neighbourhood
attributes related to walking for exercise or transport (i.
e., aesthetics, convenience, access and traffic); answered
on an 11-point scale (-5 = strongly disagree; +5 =
strongly agree, with 0 = neutral option). The items were
selected or modified from existing instruments
[101,102].
Cost-effectiveness
Health-related quality of life The Short-Form (SF)-12
Version 2 Health Survey [103], validated for use in Aus-
tralia [104,105], is used to assess health-related quality
of life across eight dimensions - physical functioning,
social functioning, role limitations due to physical pro-
blems, role limitations due to emotional problems, bod-
ily pain, vitality, general health and mental health. To
enable economic analysis, the SF-12 is converted to EQ-
5 D preference based utility values via an algorithm
developed by Gray and colleagues [106].
Health care utilisation Measured using 9-items asses-
sing doctor and allied health care visits and hospital
stays in the past six months [107]. Dollar valuations of
these resources are obtained from the Commonwealth
Government schedule of re-imbursements [108] and are
used in cost-effectiveness analysis.
Intervention costs Costs to deliver the intervention, not
including the research/assessment components, are used
in the cost-effectiveness analysis. They are tracked during
trial implementation and include the cost of counsellor
time, intervention materials (workbook, pedometer,
stretch band, scale) and related infrastructure (i.e., office
space, telephones, computers and call costs).
Patient safety
A number of strategies are used to ensure patients’ safety.
Intervention participants who identify new health concerns
or questions about the medical management of diabetes
are recommended to visit their GP to seek advice. Any
participant who indicates suicidal ideation on the PHQ-9
scale is contacted by the project manager and informed
that their GP will be notified and a 24-hour telephone cri-
sis service number is provided. Adverse outcomes are also
systematically monitored, as described below.
Adverse outcomes monitoring system
Adverse outcomes are assessed at each follow-up tele-
phone interview by asking participants if they have had
any new health problems since the previous contact, with
the following examples provided: any new diagnoses of
medical conditions or illnesses, such as a heart attack or
cancer, any periods of hospitalisation or surgery, any
muscle injuries, bone or joint problems, or any new
symptoms or worsening of pre-existing conditions.
Responses are recorded verbatim and then coded inde-
pendently by two of the study investigators, first as “ser-
ious” (i.e., requiring hospitalisation) versus not, and then
as “directly attributable to the study” (i.e., exercise-related
pain or muscle injury, digestive disturbances related to
dietary changes) versus not, with input on disagreements
discussed with a researcher independent of the trial.
Statistical analyses
Primary and secondary outcomes
Data will be analysed using intention-to-treat principles.
Once a participant is randomised into a study group,
they will be considered a trial participant and analysed
according to their allocated group, regardless of missing
data for follow-ups or the amount of intervention
received. Each primary and secondary outcome will be
modelled using mixed linear models with random inter-
cepts, the fixed effects of study group, time and a group
by time interaction as well as baseline values (to account
for regression to the mean). Potential confounders
include baseline characteristics and the factors used to
balance groups by minimisation. Confounders will be
identified by forwards and backwards selection. Inclu-
sion in the final model will require the addition or omis-
sion of the potential confounder to elicit a substantial
change in the coefficient for the effect of intervention. A
20% change in coefficient will be considered substantial
unless the coefficient is close to zero. Data analysis will
be performed using [SAS/STAT] software, Version [9.2]
of the SAS system for Windows. Statistical significance
will be set at the conventional two-tailed 5% level.
Incremental cost-effectiveness
A probabilistic decision analytic Markov model developed
for our recent telephone-delivered lifestyle intervention
trial will be adapted and used to evaluate incremental
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cost-effectiveness [42]. The structure, data requirements,
methods for calibration and model evaluation are
described in a recent methodological peer reviewed publi-
cation [91]. The model describes the health states relevant
to intervening on weight loss, physical activity, and glycae-
mic control in adults with type 2 diabetes. A societal per-
spective is adopted and values collected for variables that
describe the participant’s use of acute and primary care
health services, their private out of pocket expenditures
and the time costs to informal carers. Patient-based pro-
duction losses are not included on the cost side of the ana-
lysis but (implicitly) counted within the QALY estimation
in line with current theory and recommendations [92].
The model implies the trial participants face some prob-
ability of remaining in a sub-optimal health state or transi-
tioning to improved health states (i.e. improvements in
weight, physical activity and glycaemic control) and there
will be a small chance of transitioning to death. Cycle
duration is based on the timing of data collection for
health-related quality of life (i.e. baseline, 6, 18, and 24
months). The transition probabilities that reflect consis-
tency with study intervention targets surrounding primary
outcomes (i.e., 5% weight loss, 210 min/wk moderate-to-
vigorous PA, < 7% HbA1c) will be used to predict move-
ment through the states for all cycles; this approach is
shown in a previous economic analysis [42]. Costs and uti-
lity based preference scores will be estimated for each
cycle and summarised to estimate change in costs and
change in QALYs. The relevant ICER will be estimated
and cost-effectiveness acceptability curves plotted to illus-
trate the probability that the intervention is cost-effective
[109].
Moderators and mediators of outcome
Exploratory analyses will be conducted to determine
whether there is moderation or mediation of interven-
tion effects using previously established methods
[95,96]. Moderator analysis will determine whether
intervention effects differ across demographic (e.g. age,
gender) and medical (e.g. insulin use) characteristics and
will be performed by considering the statistical signifi-
cance of an interaction between a potential moderator
and the intervention using a Wald test.
Mediator analysis will determine whether theoreti-
cally-driven constructs and mechanisms for behaviour
change do in fact mediate the intervention effects.
Potential mediators will be assessed using path analysis.
Point estimates and bootstrap confidence intervals of
path coefficients and the product of the mediated path
coefficients will be used to determine the potency, cer-
tainty and direction of any mediation effect [110].
Sample size
Effect size estimates for the proposed study take into
account clinically meaningful differences and are based
on published results [24,111,112], and unpublished data
from our recent trials. The minimum differences of
interest in change from baseline to 18-months follow-up
between intervention and usual care groups for our pri-
mary outcomes are: -5% of initial body weight; +60 min-
utes/week for moderate physical activity; -0.6% for
HbA1c. Sample size estimates are based on the expected
mean difference for physical activity, as this variable
required the largest sample size. To detect a mean dif-
ference of 60 minutes per week change in acceler-
ometer-derived moderate-to-vigorous intensity physical
activity between the intervention and control groups
with 90% power and 5% significance (two-tailed), assum-
ing a standard deviation of 140 minutes (based on
unpublished data), requires 115 subjects per group.
Assuming an attrition rate of 30% means that 150 parti-
cipants per group are required (300 participants overall).
This sample size provides sufficient power (80% or
more) to detect the following intervention effects for
sedentary time (-45 minutes/day); light intensity time
(+30 minutes/day); and, our secondary outcomes: -2,000
kJ for energy intake; -5% for energy from fat; -2% for
energy from saturated fat; -5 to 10% for cholesterol
(total, LDL-, HDL-); -15% for triglycerides; -1 mmol/L
for fasting plasma glucose; -5 mmHg for systolic blood
pressure; -5 cm for waist circumference; and, -2% for
body fat.
Discussion
The epidemic of type 2 diabetes shows no signs of abat-
ing. Both weight loss and physical activity are indepen-
dently associated with improved glycaemic control,
lipids and blood pressure in type 2 diabetes [49] and are
important diabetes management goals. Thus there is a
need to develop, evaluate and disseminate approaches
that are effective in promoting the maintenance of
weight loss and physical activity. Telephone-delivered
interventions show promise in this regard as they facili-
tate, in a cost-effective manner, [42] the repeated con-
tacts and support necessary to promote maintenance.
The Living Well with Diabetes study is evaluating a
broad reach strategy (telephone counselling), with
emphasis on behavioural and physiologic outcomes,
fidelity of implementation, incremental cost-effective-
ness, and assessment of maintenance. These issues are
important to advancing the science of mass reach
approaches to weight management and health behaviour
change, as well as building the evidence base for the
translation of this work into population health practice.
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